Why should the need for Pfizer Limited's Conjugated Oestrogens 0.625 mg coated tablets be reassessed periodically during treatment of menopausal symptoms?

The need for Pfizer Limited's Conjugated Oestrogens 0.625 mg coated tablets should be reassessed periodically to determine whether symptom treatment remains necessary, using the lowest effective dose for the shortest duration.